George E. Revtyak

622 total citations
16 papers, 301 citations indexed

About

George E. Revtyak is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Biochemistry. According to data from OpenAlex, George E. Revtyak has authored 16 papers receiving a total of 301 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Biochemistry. Recurrent topics in George E. Revtyak's work include Eicosanoids and Hypertension Pharmacology (6 papers), Nitric Oxide and Endothelin Effects (5 papers) and Inflammatory mediators and NSAID effects (5 papers). George E. Revtyak is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (6 papers), Nitric Oxide and Endothelin Effects (5 papers) and Inflammatory mediators and NSAID effects (5 papers). George E. Revtyak collaborates with scholars based in United States. George E. Revtyak's co-authors include William B. Campbell, Alice Johnson, Donald S. Baim, John Katopodis, David A. Cox, Joseph B. Muhlestein, John M. Lasala, W B Campbell, L. Maximilian Buja and Kenneth R. Chien and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Critical Care Medicine.

In The Last Decade

George E. Revtyak

15 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
George E. Revtyak United States 8 98 93 81 77 66 16 301
Nabil Foudi France 10 87 0.9× 73 0.8× 79 1.0× 91 1.2× 87 1.3× 16 402
Sheldon Y. Freeberg United States 6 66 0.7× 52 0.6× 95 1.2× 107 1.4× 107 1.6× 7 363
Cornell Mallari United States 5 52 0.5× 114 1.2× 55 0.7× 167 2.2× 75 1.1× 10 377
Gülsev Özen Türkiye 12 82 0.8× 92 1.0× 106 1.3× 159 2.1× 75 1.1× 26 399
Tadashi Seno Japan 6 47 0.5× 95 1.0× 43 0.5× 68 0.9× 136 2.1× 6 430
Antony Lau Australia 9 43 0.4× 77 0.8× 116 1.4× 111 1.4× 191 2.9× 9 493
Ingrid Gomez France 11 93 0.9× 103 1.1× 127 1.6× 145 1.9× 94 1.4× 16 495
E Kostka-Trąbka Poland 10 37 0.4× 66 0.7× 54 0.7× 85 1.1× 39 0.6× 33 322
Syed R. Baber United States 13 60 0.6× 100 1.1× 114 1.4× 104 1.4× 101 1.5× 22 450
Yukage Kobari United States 5 48 0.5× 179 1.9× 61 0.8× 178 2.3× 73 1.1× 7 416

Countries citing papers authored by George E. Revtyak

Since Specialization
Citations

This map shows the geographic impact of George E. Revtyak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George E. Revtyak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George E. Revtyak more than expected).

Fields of papers citing papers by George E. Revtyak

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George E. Revtyak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George E. Revtyak. The network helps show where George E. Revtyak may publish in the future.

Co-authorship network of co-authors of George E. Revtyak

This figure shows the co-authorship network connecting the top 25 collaborators of George E. Revtyak. A scholar is included among the top collaborators of George E. Revtyak based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George E. Revtyak. George E. Revtyak is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Morris, Michelle, et al.. (2023). B-9 | Gender Differences in Procedural Complications of Atherectomy. Journal of the Society for Cardiovascular Angiography & Interventions. 2(3). 100729–100729.
2.
Kreutz, Rolf P., Hamid Reza Bahrami, Anjan Sinha, et al.. (2022). Femoral Artery Closure Devices vs Manual Compression During Cardiac Catheterization and Percutaneous Coronary Intervention. Journal of the Society for Cardiovascular Angiography & Interventions. 1(5). 100370–100370. 2 indexed citations
3.
Guglin, Maya, et al.. (2021). Isolated congenital cleft mitral valve leaflet: a rare cause of refractory cardiogenic shock complicating acute myocardial infarction. SHILAP Revista de lepidopterología. 5(1). 1 indexed citations
4.
Guglin, Maya, et al.. (2020). A safe and simple method for axIABP placement using a left axillary–radial technique. Catheterization and Cardiovascular Interventions. 98(2). E310–E314. 1 indexed citations
5.
Lee, Michael S., Richard Shlofmitz, Evan Shlofmitz, et al.. (2018). Procedural and Long-Term Ischemic Outcomes of Tight Subtotal Occlusions Treated with Orbital Atherectomy: An ORBIT II Subanalysis. Cardiovascular revascularization medicine. 20(7). 563–568. 1 indexed citations
6.
Revtyak, George E., et al.. (2014). Treatment of Radial Artery Occlusions Using Balloon Angioplasty and Localized Intra‐Arterial Abciximab. Journal of Interventional Cardiology. 27(2). 217–222. 12 indexed citations
7.
Maluenda, Gabriel, et al.. (2013). Intracoronary glycoprotein IIb/IIIa inhibitor infusion via a perfusion coronary catheter to decrease thrombus burden: Results from the ClearWay™ Multicenter Registry. Cardiovascular revascularization medicine. 14(5). 280–283. 7 indexed citations
8.
Lasala, John M., David A. Cox, Joseph B. Muhlestein, et al.. (2008). Usage patterns and 2‐year outcomes with the TAXUS express stent: Results of the US ARRIVE 1 registry. Catheterization and Cardiovascular Interventions. 72(4). 433–445. 34 indexed citations
9.
Revtyak, George E. & William B. Campbell. (1992). Inhibition of prostaglandin synthesis in human endothelial cells treated with metabolic inhibitors. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1123(2). 216–226. 3 indexed citations
10.
Revtyak, George E., L. Maximilian Buja, Kenneth R. Chien, & W B Campbell. (1990). Reduced arachidonate metabolism in ATP-depleted myocardial cells occurs early in cell injury. American Journal of Physiology-Heart and Circulatory Physiology. 259(2). H582–H591. 17 indexed citations
11.
Steinhelper, Mark E., Rory A. Fisher, George E. Revtyak, D J Hanahan, & Merle S. Olson. (1989). β2-Adrenergic Agonist Regulation of Immune Aggregate- and Platelet-activating Factor-stimulated Hepatic Metabolism. Journal of Biological Chemistry. 264(19). 10976–10981. 15 indexed citations
12.
Revtyak, George E., et al.. (1988). Histamine stimulation of prostaglandin and HETE synthesis in human endothelial cells. American Journal of Physiology-Cell Physiology. 255(2). C214–C225. 54 indexed citations
13.
Revtyak, George E., Alice Johnson, & William B. Campbell. (1988). Cultured bovine coronary arterial endothelial cells synthesize HETEs and prostacyclin. American Journal of Physiology-Cell Physiology. 254(1). C8–C19. 72 indexed citations
14.
Revtyak, George E., Alice Johnson, & William B. Campbell. (1987). Prostaglandin synthesis in bovine coronary endothelial cells: comparison with other commonly studied endothelial cells. Thrombosis Research. 48(6). 671–683. 32 indexed citations
15.
Revtyak, George E., et al.. (1985). Arachidonic acid metabolites and endothelial injury: studies with cultures of human endothelial cells.. PubMed. 44(1 Pt 1). 19–24. 45 indexed citations
16.
McGrath, Roland B. & George E. Revtyak. (1984). Secondary myocardial injuries. Critical Care Medicine. 12(12). 1024–1026. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026